4 ms·
That is not right at all.
by dbbk 6y ago
That is not right at all.
- oytis 6y agoThat's what I read in AstraZeneca press-release. > The MHRA’s decision was based on ... _interim_ analysis of the Phase III programme > Additional safety and efficacy data for the vaccine will continue to accumulate from _ongoing_ clinical trials. https://www.astrazeneca.com/media-centre/press-releases/2020/astrazenecas-covid-19-vaccine-authorised-in-uk.html https://www.astrazeneca.com/media-centre/press-releases/2020...